| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/06/2006 | US20060148687 Proteolysis resistant active vegf |
| 07/06/2006 | US20060148682 Identifying substrate of an enzyme that is secreted by MCF7/6, HepG2, or HT29 cells; covalently attaching by amidation or esterification the substrate to drug to form a prospective tumor-activated prodrug; drug screening and testing; antitumor, antiinflammatory and anticarcinogenic agents; diagnosis |
| 07/06/2006 | US20060148680 Glycoproteins produced in plants and methods of their use |
| 07/06/2006 | US20060148679 Glycosolated enkephalin agents |
| 07/06/2006 | US20060148677 Chondrogenesis stimulator |
| 07/06/2006 | US20060148101 Fluorescent ligands for GPCR arrays |
| 07/06/2006 | US20060148087 Development of a preventive vaccine for filovirus infection in primates |
| 07/06/2006 | US20060148086 Vault and vault-like carrier molecules |
| 07/06/2006 | US20060148074 Serum-free mammalian cell culture medium, and uses thereof |
| 07/06/2006 | US20060148060 Biomolecule transduction motif Mph-1-BTM and the use thereof |
| 07/06/2006 | US20060148058 N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-4-(4-methyl-piperazin-1-ylmethyl)-benzamide methanesulfonate; detecting a mutant Abl kinase domain; tumors; leukemia |
| 07/06/2006 | US20060148055 Oxidised fragments of apolioprotein B and their uses |
| 07/06/2006 | US20060148050 Yeast strains for the production of lactic acid |
| 07/06/2006 | US20060148049 Gene disrupted yeast |
| 07/06/2006 | US20060148038 Thrombin cleavable factor x analogues |
| 07/06/2006 | US20060148037 amino acid sequence is encoded by nucleotide sequences, a potassium channel modulators; cell producing a membrane protein associated with ionic mobility for detecting and preventing pancreatic disorders; diagnose diabetes; producing biodrug for treating type 1 and type 2 diabetes |
| 07/06/2006 | US20060148036 GABAalpha receptor epsilon subunits |
| 07/06/2006 | US20060148032 Novel phosphoprotein |
| 07/06/2006 | US20060148030 Nuclear receptor err y 3 |
| 07/06/2006 | US20060148029 Lactoferricin gene and transformant expressing lactoferricin |
| 07/06/2006 | US20060148026 Engineering redox proteins |
| 07/06/2006 | US20060148021 Extraction of a proteinaceous macromolecule from a biological sample |
| 07/06/2006 | US20060148017 Compositions and methods for monitoring enzyme activity |
| 07/06/2006 | US20060148013 use of RL9/RL10 protein and the polynucleotides encoding RL9/RL10 protein, e.g., in diagnosing and treating tumor, as well as the pharmaceutical composition containing RL9/RL10 protein or the antibody against it |
| 07/06/2006 | US20060148011 Diagnosing prostate cancer by contacting a biological fluid sample (plasma) or prostatic tissue specimen from the subject with an antibody which binds to SEQ ID NO: 1, detecting binding of the antibody in the specimen and correlating the detected binding to prostate cancer |
| 07/06/2006 | US20060148010 Isolation and purification of P. falciparum merozoite protien-142 vaccine |
| 07/06/2006 | US20060148005 Biologically active synthetic thyrotropin and cloned gene for producing same |
| 07/06/2006 | US20060148002 Methods and compositions for the treatment and diagnosis of body weight disorders |
| 07/06/2006 | US20060147992 Method for detection of bioactive peptides |
| 07/06/2006 | US20060147988 Vertebrate transmembrane protein (UNC-5 protein) for use in diagnosis, prevention and treatment of nervous system disorders |
| 07/06/2006 | US20060147987 Bivalent binding molecules of 7 transmembrane G protein-coupled receptors |
| 07/06/2006 | US20060147986 Gene and protein libraries and methods relating thereto |
| 07/06/2006 | US20060147982 32 human secreted proteins |
| 07/06/2006 | US20060147978 Methods and compositions for screening for altered cellular phenotypes |
| 07/06/2006 | US20060147974 Novel Drosophila tumor necrosis factor class molecule ("DmTNF") and variants thereof |
| 07/06/2006 | US20060147973 Polynucleotide encoding a novel human serpin secreted from lymphoid cells, LSI-01 |
| 07/06/2006 | US20060147951 "STRAP" and "STEAP" (six transmembrane epithelial antigen of the prostate) |
| 07/06/2006 | US20060147946 Novel calcium channel variants and methods of use thereof |
| 07/06/2006 | US20060147928 Novel real-time rt-pcr for the sensitive detection of multiple mage gene transcripts |
| 07/06/2006 | US20060147923 Nucleic acid sequences encoding novel point mutations on mglur2 and mglur3 |
| 07/06/2006 | US20060147908 "Prionins", highly specific markers for noninvasive presymptomatic detection of TSE diseases, and targets for therapeutic reagents to prevent and control TSE diseases in animals and humans. |
| 07/06/2006 | US20060147906 Anti-hpv-16 e7 antibodies and their use |
| 07/06/2006 | US20060147477 Immunogenic compositions |
| 07/06/2006 | US20060147474 Detection of antibodies against chamydia trachomatis PGP3 antigen in patient sera by enzyme-linked immunoassay |
| 07/06/2006 | US20060147470 Cross-protective epitopes of moraxella catarrhalis and use thereof |
| 07/06/2006 | US20060147469 Recombinant hepatitis a virus antigens obtained in plant cells |
| 07/06/2006 | US20060147467 Materials and methods for immunizing against FIV infection |
| 07/06/2006 | US20060147464 immunogens; immunololgy; for production of vaccines; able to induce antiserum having neutralizing antibody; neutralization assay; Mareks Disease virus, infectious bronchitis virus, Newcastle disease virus, egg drop syndrome virus, turkey rhinotracheitis virus, or reovirus |
| 07/06/2006 | US20060147463 HSP20 inhibits amyloidogenesis and neurotoxicity |
| 07/06/2006 | US20060147462 For diagnostic, prophylactic and therapeutic uses, vaccines against bacterial infections |
| 07/06/2006 | US20060147460 vaccinating a patient against a malignancy by introducing a protein or peptide comprising all or an immunogenic fragment of a cyclin protein into the patient |
| 07/06/2006 | US20060147458 Vaccines |
| 07/06/2006 | US20060147455 Gastric and colon cancer-associated antigens |
| 07/06/2006 | US20060147454 Human serine protease and serpin polypeptides |
| 07/06/2006 | US20060147447 Secreted peptides |
| 07/06/2006 | US20060147439 Protein isolated from plants (Moringa) or recombinant DNA; enzyme inhibitors; prevention and treatment of metabolic, cardiovascular, and inflammatory diseases |
| 07/06/2006 | US20060147436 interferon type 1 receptor 1 (IFNAR1)-binding proteins, used to enhanced the exogenous therapy or treatment of cancer |
| 07/06/2006 | US20060147428 Allogeneic and xenogeneic transplantation |
| 07/06/2006 | US20060147421 Methods and compositions for treating and preventing infection using human interferon regulatory factor 3 |
| 07/06/2006 | US20060147420 Oncolytic adenovirus armed with therapeutic genes |
| 07/06/2006 | US20060147418 Recombinant double stranded rna phages and uses thereof |
| 07/06/2006 | US20060147417 Immunogenic composition comprising an il-13 element and t cell epitopes, and its therapeutic use |
| 07/06/2006 | US20060147409 Biodegradable hydrogel having a visualization agent that reflects or emits light at a wavelength detectable to a human eye for minimal invasive surgery; crosslinked synthetic polymer having electrophilic functional groups and dilysine, trilysine or tetralysine; dyes provide green color |
| 07/06/2006 | US20060147378 Azulene dimer-quenched, near-infrared fluorescent probes |
| 07/06/2006 | US20060147377 tumor cell line, reponsive to histone deacetylase inhibitors, transfected with vector containing reporter gene such as fluorescent protein, linked to promotor that also controls expression of protein associated with tumor regression, stabilization of tumor growth or inhibition of metastatic growth |
| 07/06/2006 | US20060147372 DNA encoding MCK-10, a novel receptor tyrosine kinase |
| 07/06/2006 | US20060144876 Lock for a flat and low pourer with a removable element in the form of a laminate of film for a composite package for container openings closed by nonpermeable film |
| 07/06/2006 | DE102004062420A1 Verfahren zur Isolierung neuraler Zellen mit Tenascin-R-Verbindungen Method for the isolation of neural cells with tenascin-R compounds |
| 07/06/2006 | DE102004061903A1 New isolated polynucleotide based on gene isolated from Heliothis virescens, encoding insect neurokinin receptor, useful as target in screening for receptor modulating pesticides |
| 07/06/2006 | CA2610360A1 E1-minus adenoviruses and use thereof |
| 07/06/2006 | CA2595162A1 Pulmonary surfactant formulations |
| 07/06/2006 | CA2594561A1 Formulations of human growth hormone comprising a non-naturally encoded amino acid |
| 07/06/2006 | CA2594289A1 Anti-human soluble fibrin monoclonal antibody and immunological assay method using the antibody |
| 07/06/2006 | CA2593866A1 Synthesis of peptide t-1249 using peptide intermediate fragments |
| 07/06/2006 | CA2593864A1 Synthesis using peptide intermediate fragments iii |
| 07/06/2006 | CA2592894A1 Improved grain quality through altered expression of gamma-zein protein |
| 07/06/2006 | CA2592699A1 Method for reversing multiple resistance in animal cells |
| 07/06/2006 | CA2592690A1 Immunogenic compositions of cyclic peptides derived from the beta-amyloid peptide |
| 07/06/2006 | CA2592466A1 Human protooncogene and protein encoded therein |
| 07/06/2006 | CA2592438A1 Synthesis of peptide t-20 using peptide intermediate fragments |
| 07/06/2006 | CA2592397A1 Human cancer suppressor gene, protein encoded therein, expression vector containing same |
| 07/06/2006 | CA2592100A1 Methods to obtain recombinant proteins with increased sialylation from cells that express adenovirus e1a protein, and proteins obtained thereby |
| 07/06/2006 | CA2591403A1 Rnai inhibition of serum amyloid a for treatment of glaucoma |
| 07/06/2006 | CA2591311A1 Multiple promoters and the use thereof for gene expression |
| 07/05/2006 | EP1677113A1 Method for the identification of protein-protein interactions in disease related protein networks |
| 07/05/2006 | EP1677112A1 Immunoassay |
| 07/05/2006 | EP1676927A2 Diagnosis of diseases associated with development by means of assessing their methylation status |
| 07/05/2006 | EP1676922A2 Plant-optimized genes encoding pesticidal toxins |
| 07/05/2006 | EP1676921A1 Utilization of zpt2-3 zinc finger type transcriptional factor in constructing plant with enhanced resistance to dryness |
| 07/05/2006 | EP1676920A2 Anticoagulant fusion protein anchored to cell membrane |
| 07/05/2006 | EP1676916A1 Hamster EF-1Alpha transcriptional regulatory DNA |
| 07/05/2006 | EP1676911A1 Novel recombinant animal cells with high protein production, method of constructing the same and method of mass protein production using the same |
| 07/05/2006 | EP1676861A2 Non-endogenous, constitutively activated human G protein-coupled receptors |
| 07/05/2006 | EP1676860A1 Process for producing antithrombin iii composition |
| 07/05/2006 | EP1676859A1 Immunogenic compositions of cyclic peptides derived from the beta-amyloid peptide |
| 07/05/2006 | EP1676858A2 Chimeric avidin mutants |
| 07/05/2006 | EP1676857A2 Receptor that binds trail |
| 07/05/2006 | EP1676856A1 Peptide originating in hepatitis c virus |
| 07/05/2006 | EP1676590A1 Oncogene therapeutic drug |
| 07/05/2006 | EP1676589A1 Oncogene therapeutic drug |